RxDoctor Payments Data

Megan Patrick, NP

Family · Kingstree, SCNPI 1801419213

Payments from drug & device makers

$925in general payments, 2019–2025

Across 52 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$153
  • AbbVie$146
  • Novo Nordisk$93
  • GSK$72
  • Amgen$67
  • Dexcom, Inc.$57
  • plus $338 from 12 others

What the payments were for

  • Food & beverage$925100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$925 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$10,106
Medicare patients
130
Services billed
543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide78$80,837
MounjaroTirzepatide41$47,587
FarxigaDapagliflozin Propanediol40$29,101
TrulicityDulaglutide19$26,448
JardianceEmpagliflozin23$21,708
EliquisApixaban26$17,720
JanuviaSitagliptin Phosphate14$16,565
Tresiba Flextouch U-100Insulin Degludec27$14,301
VimpatLacosamide12$13,521
XareltoRivaroxaban13$12,226
Breo ElliptaFluticasone/Vilanterol22$9,681
SymbicortBudesonide/Formoterol Fumarate17$5,259
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$4,214
Rosuvastatin Calcium201$2,900
Omeprazole170$2,842

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$93$80,83778 claims
Lilly USA, LLCMounjaro, Trulicity$44$74,03660 claims
AstraZenecaFarxiga, Symbicort$153$34,36057 claims
Boehringer IngelheimJardiance$35$21,70823 claims
MerckJanuvia$35$16,56514 claims
GSKBreo Ellipta$72$9,68122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,248 family providers in South Carolina.

Other family in Kingstree

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →